Successful Resuscitation of Deadly SARS - Cov-2 / COVID19

Abstract

I survived in April 2020 from the deadly β- SARS-Cov-2/ COVID-19, as a resuscitator who saved many thousands of other patients in Moldova, Russia and Middle Asia. I consider it necessary to describe the success of Professor V. Cojocaru’s team in saving my life. Constant multifunctional monitoring, laboratory tests, markers, including arterial and all other survey methods were carried out according to National Protocols and the WHO. Treatment of interspecific COVID-19 with the manifestation of MODS was guided by the “Surviving Sepsis COVID-19” using MOST-ELSO. Modeling of the index of extravascular pulmonary fluid EVLWI. If EVLWI is <10 mL/kg this indicates alveolar atelectasis which requires volemic resuscitation, bronchoscopy, alveolar recruitment and surfactant therapy. In situations where EVLWI is >10 mL/kg, which is a threat to pulmonary edema which requires a reduction in volemic resustation and the inclusion of diuretics (Manitol), ultrafiltration and MOST-ELSO, inotropic therapy and blood arterial monitoring. Mechanical ventilation with alveolar recruitment. Microcirculatory-mitochondrial recruitment to by ↓ the tissue hypoxia marker pCO2 AV gap>6 mmHg and extracorporeal detoxification (Plasmapheresis-three times with plasma exfusion in the amount of 800; 600; 400 ml). Crystalloids (Sterofundin, Reosorbilact) were used. Hydroxyethyl starches and Dextrans were not used. Perfusion pressure was maintained by Norepinephrine. Bradycardia was eliminated by Atropine.